Genenta Science Shifts to Defense Business, Changing Name to Saentra Forge

Genenta Science SPA (NASDAQ:GNTA) is shifting its business strategy from biotech to defense and national security. The company plans to acquire private Italian businesses in the national security sector, with a focus on profitable businesses generating €5 million in annual EBITDA. Genenta has struck a deal with ATC, a tactical rifles and special-forces weapon systems maker, and plans to continue its biotech programs through partnerships. The company will hold an extraordinary shareholders meeting on March 26 to discuss the name change to Saentra Forge.